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The interaction of Escherichia  coli glutamine synthe- 
tase with the adenosine 5’4riphosphate analogue, 5‘-p- 
fluorosulfonylbenzoyladenosine (5’-FSO2BzAdo), has 
been studied. This interaction  results in the covalent 
attachment of the 5’-FS02BzAdo to the enzyme with 
concomitant loss of catalytic activity. Although adenine 
nucleotides interact with glutamine synthetase at 
three distinct sites-a noncovalent AMP effector site, 
a regulatory site of covalent adenylylation, and the 
catalytic ATP/ADP binding site-our studies suggest 
that reaction with 5’-FSOzBzAdo occurs only at the 
active center. When glutamine synthetase was incu- 
bated with 5’-FSO2BzAdo, the decrease in catalytic ac- 
tivity obeyed pseudo-first order kinetics. The plot of 
the observed rate constant of inactivation versus the 
concentration of 5’-FSOzBzAdo was hyperbolic, con- 
sistent with reversible binding of the analogue to  the 
enzyme prior  to covalent attachment. Protection 
against inactivation was afforded by  ATP and ADP; L- 
glutamate did not protect the enzyme against inacti- 
vation, but rather enhanced the rate of inactivation, 
consistent with the observations of others (Timmons, 
R. B., Rhee, S. G., Luterman, D. L., and Chock, P. B. 
(1974) Biochemistry 13,4479-4485) that  there  is  syner- 
gism in the binding of the two substrates  to  the enzyme. 
The incorporation of approximately 1.09  mol of the 5’- 
FS02BzAdo/mol of glutamine synthetase subunit re- 
sulted in the  total oss of enzymatic activity. The results 
suggest that 5’-FSO2BzAdo occupies the ATP binding 
site at the active center of glutamine synthetase  and 
binds covalently to  an amino acid residue nearby. 
The glutamine  synthetase of Escherichia coli is composed 
of  12 identical subunits (1) with  a  molecular weight of approx- 
imately 49,00O/subunit. On each  subunit  there exists a regu- 
latory site of covalent adenylylation (2, 3), a catalytically 
active  center,  and at  least two distinct  metal ion binding sites: 
the nl site  and  the n2 site  (4,5).  Studies by Hunt et  al. (4)  and 
Hunt and Ginsburg (5) have demonstrated that metal ion 
bound to  the high  affinity nl site is responsible for maintaining 
an active conformation of the enzyme, whereas metal ion 
bound to  the n2 site chelates the nucleotide substrate.  The 
physical  relationships of these  sites  have been reviewed re- 
cently by ViUafranca and  Balakrishnan (6). 
Extensive work has been  done on the inactivation of gluta- 
mine synthetase by the proposed transition  state analogue, 
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L-methionine-SR-sulfoximine (5-9). This analogue has been 
shown to form,  in the presence of ATP  and Me”, methionine 
sulfoximine phosphate, in  which the sulfoximine nitrogen has 
been phosphorylated.  This  phosphorylated derivative remains 
bound to  the enzyme  active center ( 7 ) .  Hunt  and Ginsburg (5) 
have  shown  that  the binding of methionine sulfoximine to the 
enzyme is near  the nl metal ion  site. 
To  date  there  have been  comparatively few reports on the 
interaction of glutamine  synthetase with  analogues of ATP  or 
ADP. Rhee e.? al. (10) have shown that  ADP  binds competi- 
tively with respect to ATP, while other studies (11) have 
demonstrated  strong synergism of binding  between L-gluta- 
mate  and  ATP. Pillai et al. (12) have  reported recently on the 
interaction of glutamine synthetase  and stereoisomers of thio- 
phosphate esters of ATP and ADP, showing that in the 
reactions catalyzed by the enzyme, metal ions bind to  both 
the a- and P-phosphoryl  groups of ATP  or ADP. The  present 
study was undertaken  to examine the  interaction of E. coli 
glutamine  synthetase with an analogue of the  substrate  ATP, 
5’-p-fluorosulfonylbenzoyladenosine, developed by Pal et al. 
(13). 5”FS02BzAdo‘ has been  shown to label  covalently either 
regulatory or  catalytic  sites of dehydrogenases (13,141, kinases 
(15-19), F,-ATPase (20, 21), and  an ADP-binding  protein in 
human  platelets (22). The  present  report deals with studies 
on  the  inactivation of glutamine  synthetase by 5’-FS02BzAdo. 
Preliminary  reports of these  studies  have been presented (23, 
24). 
EXPERIMENTAL  PROCEDURES 
Materials 
5-FS02BzAdo was either  prepared  as described below or purchased 
from Sigma as the HCI salt.  ATP,  ADP,  AMP, L-glutamate, L-gluta- 
mine, 4-morpholinopropanesulfonic acid, and imidazole were also 
purchased  from Sigma. Reagents for polyacrylamide gel electropho- 
resis, including  sodium  dodecyl  sulfate-polyacrylamide gel electropho- 
resis molecular weight standards, were purchased from Bio-Rad. 
Hexamethylphosphoramide, p-fluorosulfonylbenzoylchloride, and 
adenosine were purchased from Aldrich. Cellulose thin layer chro- 
were obtained from  Schleicher & Schuell  as well as from Eastman. 
matography  sheets  and silica gel thin layer chromatography  sheets 
All other chemicals used in  this  study were reagent grade. 
Kilogram quantities of E.  coli W were supplied by Dr. David 
Novelli, E. F. Phares, and Mary Long of the Oak Ridge National 
Laboratory, Oak Ridge, TN, and were grown by the procedure of 
Phares (35). Bacterial cell paste was shipped to us packed in dry ice 
and was stored at  -20°C until used. 
Methods 
Preparation of Buffers-All buffers used in this  study were pre- 
pared  and  adjusted to the  proper  pH a t  room temperature. A Radi- 
’ The abbreviations used are: 5’-FS02BzAdo, 5”p-fluorosulfonyl- 
benzoyladenosine; Me2S0,  dimethyl sulfoxide; EtOH,  ethanol. 
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ometer  PHM62  pH-meter  (The London Company, Cleveland, OH) 
equipped  with  a  combination  electrode  was  calibrated for use at  room 
temperature. 
Purification of Glutamine Synthetase-The  glutamine synthetase 
used for these  studies was purified by the procedure of Woolfolk et 
a1. (26),  with omission of the final crystallization step.  Purity of the 
enzyme preparation was assessed by polyacrylamide gel electropho- 
resis  by the procedure of Weber and Osborn (27), as well as by NH2- 
terminal sequence analysis of the intact protein which had been 
dialyzed exhaustively against distilled water. The average state of 
adenylylation of the enzyme preparation was determined  both spec- 
trophotometrically  (28), and enzymatically according to  Stadtman et 
al. (29). The enzyme used in these  studies contained an average of 1.9 
adenylyl  groups/dodecamer. 
Assay of Enzymatic Activity-Glutamine synthetase catalyzes  sev- 
eral reactions,  including those described by Equations 1 and 2. 
ATP + NH? + L-Glu .”--- ADP + L-Gln + P, (1) Me2+ 
NHpOH + L-Gln . ADP, arsenate 
Me2+ 
y-glutamylhydroxamate + NHa 
Either of these two reactions can form the basis for an enzyme assay. 
When using the biosynthetic  assay  described by Equation 1, the  rate 
of production of inorganic phosphate was measured (26). When using 
the transferase  assay  described by Equation 2, the  rate of production 
of y-glutamylhydroxamate was measured  (26). Both assays were 
performed at  37°C. Rhee  et al. (IO) have shown that a single active 
center catalyzes both of the reactions described above. Only the 
transferase  assay was used to monitor  enzymatic activity  during  the 
purification of the enzyme. 
Protein  Concentration-The concentration of purified glutamine 
synthetase was determined spectrophotometrically as described by 
Ginsburg et  al. (30) as well a s  by the procedure of Lowry et al. (31) 
using bovine serum  albumin  as  the  standard. 
Preparation of 5’-FSO~BzAdo--5”FS02BzAdo was prepared as 
described by Wyatt and Colman (15). Radiolabeled 5’-FS02BzAdo 
was prepared by the addition of [2,8-’H]adenosine to  the unlabeled 
adenosine used in the  normal preparation. However, when  preparing 
radiolabeled 5’-FSO*BzAdo, the amount of each component was 
reduced 10-fold in  order to obtain a  higher specific radioactivity in 
the final product. The specific radioactivity of the  product was 1.67 
X 10’ cpm/mmol. The purity of the analogue preparations was 
assessed  by  a  combination of chromatographic  techniques. We have 
found that  the  thin layer  chromatographic system described by Wyatt 
and Colman (15) and Hixson and  Krebs (16) apparently results  in  a 
small amount of hydrolysis of the analogue  during the chromatogra- 
phy, thereby leading to  the  appearance of contaminating  adenosine. 
As an alternative to  thin layer, we have used high performance  liquid 
chromatography on a C-18 reverse-phase column.* The concentra- 
tions of stock 5”FSOzBzAdo solutions were determined by their 
absorbance at  232 nm (E = 18.8 cm” mM”) and a t  259 nm ( E  = 13.5 
cm” nM“), as described by Wyatt  and Colrnan (15). 
Reaction of Glutamine  Synthetase and  5’-FS02 BzAdo-Gluta- 
mine synthetase (0.385 mg/ml) was incubated with  various  concen- 
trations of 5”FSOzBzAdo at  4°C in  a  reaction  mixture  containing 0.2 
M morpholinopropanesulfonic acid buffer (pH 7.3), 5 mM MgCl2, and 
10% by volume of a 1:l (v/v) mixture of Me2S0 and EtOH. The 
organic solvent was added  to  ensure solubility of the analogue. To 
obtain the proper concentrations of 5’-FSO*BzAdo, dilutions of a 
stock solution of the analogue  (in Me,SO) were made in the Me2SO/ 
EtOH mixture  described  above. The M e  was required to  maintain 
an active  conformation of the enzyme (32.33). 
To follow the inactivation of the enzyme by 5”FS02BzAdo, 10-pl 
aliquots were withdrawn at  several times of reaction and  added  to  an 
assay tube containing (in a final volume of 1.0 ml) 0.1 M L-glutamate, 
0.05 M NH,CI, 0.05 M MgC12, 0.05 M imidazole (pH 7.0), and 0.0076 M 
ATP  at 37°C. The dilution of the analogue (1:100) plus the presence 
of the ATP quenched the reaction  of the enzyme with the 5’- 
FS02BzAdo. After  5 min, 0.20 ml was withdrawn and  added  to 1.8 ml 
of 0.8% ferrous  sulfate in 0.015 N H2S04. Color was developed by the 
addition of ammonium molybdate, and  the  absorbance  at 660 nm was 
determined in  a  Beckman  Acta CIII dual beam spectrophotometer. 
’ W. Barry Foster, Claudia M. Noyes, and Henry S. Kingdcn, 
manuscript in  preparation. 
The production of inorganic phosphate was shown to be  linear  during 
the  time of the assay.  Residual  activity is expressed as  the  ratio f the 
absorbance at  660 nm at  the indicated time of reaction ( E )  to  the 
absorbance at  660 nm at  zero time (EO). 
Stoichiometry of Inactivation-Glutamine synthetase was incu- 
bated with radiolabeled Y-FS02BzAdo as described above, except 
that the concentration of the enzyme was 1.0 mg/ml. At timed 
intervals, 1.5-ml portions of the reaction  mixture were transferred to 
tubes containing 0.15 ml of 1.0 M sodium phosphate  (pH 7.3). The 
sodium phosphate was included to  react with the excess 5” 
FS02BzAdo,  thereby quenching the reaction of the enzyme with the 
analogue (17). The samples were immediately gel-filtered through 
Sephadex (2-25 (2.5 X 10 cm), equilibrated with 0.01 M imidazole (pH 
7.0), W 4  M MnCI2, and 10% EtOH. The absorbance at 232 nm was 
monitored, and  the fractions  containing the protein were pooled and 
dialyzed against the 0.01 M imidazole (pH 7.0), M MnC12. The 
protein  concentration was determined by the  method of Lowry et  al. 
(31) using bovine serum  albumin in 0.01 M imidazole (pH 7.0), 
M MnC&  as  the  standard. 
The incorpomtion of 5’-FS02BzAdo was monitored by two meth- 
ods. For  determination of bound  radioactivity, 0.5-ml aliquots of the 
gel-filtered protein  pools were counted in an  LKB  BetaRack liquid 
scintillation counter. The incorporation was also measured  spectro- 
photometrically using the  equation derived by Shapiro  and  Stadtman 
(28) shown below. 
X = 15.3 - - 13.6 C:) (3) 
where X represents  the  number of mol of adenosine  bound/mol of 
dodecamer and  AZW - and A.m nm are  the absorbances at  260 nm  and 
290 nm,  respectively. 
RESULTS 
Inactivation of Glutamine Synthetase by 5’-FS02 BzAdo- 
When  glutamine  synthetase was incubated with 5’- 
FS02BzAdo  as described, the loss of catalytic  activity obeyed 
pseudo-first order kinetics. The  plot of the  logarithm of resid- 
ual catalytic activity uersus the time of reaction with the 
analogue was  linear (Fig. 1) as predicted by Equation 4 for a 
fist order reaction. 
log (E/Eo) = -(kotJ2.303) X t (4) 
where (E/Eo) is the residual catalytic activity, kohs is the 
observed fist order  rate  constant of inactivation, and t is the 
time of reaction with the analogue. 
The  linear  relationship described  by Equation 4 allows for 
the determination of kob from the  data  in Fig. 1. The  hyper- 
bolic relationship between the value of hobs and  the  concentra- 
tion of 5‘-FS02BzAdo  shown in Fig. 2A is consistent  with  the 
formation of a Michaelis complex between the analogue and 
the enzyme  prior to the covalent attachment of the 5’- 
FS02BzAdo  to  the nzyme, and  the  concomitant loss of cata- 
lytic  activity. This is consistent with the mechanism  described 
by Equation 5 below. 
E + Z - EI-  EZ’ k k2 
k. I 
(5) 
where E is the enzyme, Z is the 5’-FS02BzAdo, EZ is the 
Michaelis complex of E and I ,  and EI* is  the inactive, cova- 
lently modified enzyme. A steady  state  treatment of this  type 
of mechanism  as described  by Hixson and  Krebs (16)  yields 
the  relationship  in  Equation 6. 
(I/koha) = (Kl/kn)(l/[ZI) + (l/k2) (6) 
In  this  equation, Kr =E k-l/kl.  Thus, a  plot of ( l / k o b s )  uersus 
(1/5’-FS02BzAdo) should be linear  with  an x intercept value 
of - l /K, ,  and a y intercept value of l/k2.  Such a plot is shown 
in Fig. 2B. The values  for KI and k2 are 0.224 m~ and 0.232 
min”,  respectively. 
Effect  of Substrates on the Znactiuation of Glutamine Syn- 
thetase by 5’-FSO2BzAdo”To  determine  the effect of sub- 
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strates  on  the observed rate of inactivation,  reaction  mixtures 
were prepared  as described  in Table I. As shown  in this  table, 
complete  protection  against inactivation was afforded by 10 
mM ATP, 1.0 mM ATP, and 1.0 m~ ADP. When 2.27 mM 
FSOZBzAdo No 
t 0.08 OO’’j 0.171 mM 
FSOzBzAdo 
0.04 
. 0.351 mM FSOtBzAdo 
0.490 mM FSO.BzAdo 
0.03 o.oj 
0.01 ‘ I 1 I 1 
5 10 15 2; 3b 
Time (minutes) 
FIG. 1. Inactivation of glutamine synthetase by 5‘- 
FSOzBzAdo. Glutamine synthetase (0.385 mg/ml) was incubated 
with the indicated concentration of 5’-FSO*BzAdo at 4°C in 0.2 M 
morpholinopropanesulfonic acid buffer (pH 7.3) containing 5.0 mM 
MgCL and 10% Me,SO/EtOH (LI, v/v).  The loss of catalytic  activity 
was monitored  as described under  “Methods.” 
A 
I 
o.bs 0 . i ~  0.55 0.35 0.45 0.55 0.65 I I I I I ’ I I  
[FSO~BzAdo] mM 
FIG. 2. Dependence of kobs on Y-FS02BzAdo concentration. 
Glutamine  synthetase was incubated with  5’-FS02BzAdo as described 
in Fig. 1, and a value  for kohs was calculated  as described in the  text 
plotted versus the corresponding concentration of 5’-FSOZBzAdo to 
(Equation 4)  for each  concentration of the analogue  used. A, kohs is 
demonstrate  the  dependence of kuhh on the analogue concentration. 
AMP was added  to  the  reaction,  the  rate of inactivation was 
decreased. Glutamine was  shown to exert little, if any, effect 
on  the inactivation. When 1.0 m glutamate was added  to  the 
reaction, the  rate of inactivation was significantly enhanced. 
To examine this  phenomenon  further,  the  studies  represented 
in Fig. 1 were repeated, except that each reaction mixture 
contained 0.1 M glutamate,  with  the  concentrations f all other 
components as before. Treatment of these  data in the  same 
manner  as used to  construct Fig. 2B earlier yields values of KI  
and kz of 0.183 m~ and 0.375 min-I, respectively. This  decrease 
in the value of KI suggests that glutamate enhances the 
binding of the 5’-FSO*BzAdo to  the enzyme as well as increas- 
ing the  rate of covalent  bond formation. 
Competitive Binding of ATP and 5’-FSOzBzAdo”To 
demonstrate  that  5”FS02BzAdo  competes with ATP for the 
substrate binding site  at  the  active  center,  the competition 
experiments shown  in Fig. 3A were  performed. These experi- 
ments involved the  incubation of the enzyme  with 5’- 
FS02BzAdo  under assay  conditions as described  in Fig. 3A. 
The analysis of data  is in accordance with the mechanism 
described by Equation 7 .  
TABLE I 
Effect of substrates on the inactivation of glutamine  synthetase by 
Glutamine  synthetase (0.385 mg/ml) was incubated with 0.060 mM 
5“FSO*BzAdo as described in Fig. 1, except for the  indicated addition. 
The  inactivation was followed as described under  “Methods.”  The 
numbers  represent  the  percentage of residual catalytic  activity follow- 
ing incubation with the analogue for 13 min as determined by the 
biosynthetic assay reaction (Equation 1 in text). 
5“FSOa BzAdo 
Addition Residual activity 
None 42 
10 mM ATP 100 
1.0 mM ATP 98 
1.0 mM ADP 100 
1.0 mM L-glutamate 25 
1.0 mM L-glutamine 49 
2.27 mM AMP 74 
, ’PJB”, , , , B, 
. io 0 10 20 30 40 50 
1 
[FSOIB~A~O]  
mM - I  
Concentrations of 5’-FSO*BzAdo higher than  those used to construct 
this figure  were  insoluble under  the conditions of the  reaction,  and 
formed precipitates prior to  the addition of enzyme. B, the  data from 
A is replotted in double  reciprocal form  to allow determination of K I  
and k2 according to  Equation 6 in  the  text. 
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1 mM-’ 
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FIG. 3. Competitive binding of 5’-FSO2BzAdo and ATP to 
glutamine  synthetase. The Mg’+-supported biosynthetic  activity of 
glutamine  synthetase was measured in the presence of various  con- 
centrations of ATP  and 5’-FSOzBzAdo. In  addition  to  the enzyme, 
each  assay  tube  contained 0.01 M L-glutamate (pH 7.0), 0.05 M NH,Cl, 
0.05 M MgC12, 0.05 M imidazole (pH 7.0), 10% Me*SO/EtOH,  plus  the 
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FIG. 4. The stoichiometry of the  inactivation of glutamine 
synthetase by 5’-FS02BzAdo. Glutamine  synthetase (1.0 mg/ml) 
was incubated with radiolabeled 5’-FS02BzAdo and treated as de- 
scribed  under “Methods.” The gel-Ntered  samples were  analyzed for 
residual activity  in  the  Mg”-supported biosynthetic assay ( y  axis), 
the incorporation of radioactivity (O), and  the incorporation of the 
analogue  into  the enzyme as  determined  spectrophotometrically by 
the  procedure described in the  text (0). The  units of the x axis are 
moles of analogue/mol of subunit. 





Here, E is the enzyme, S is the  substrate  (ATP),  and Z is  the 
competitive inhibitor (5’-FSOzBzAdo). The relationship be- 
tween the velocity and  substrate  concentration i  the presence 
of a competitive  inhibitor  can be  described by  Equation 8. 
Thus in the presence of a  competitive inhibitor,  the  apparent 
K,, where K,,,,, = Km(l + ( [ I ] / K , ) )  increases  with increasing 
concentrations of the inhibitor, while there is no apparent 
effect on  the V,,,,,. Such  is  the case  with 5’-FSOzBzAdo and 
glutamine  synthetase as shown  in Fig. 3A. In  order  to  deter- 
mine  a  value of K, relative  to  ATP, a replot of K,,,,, uersus 
Y 
carried  out a t  37’C. A, the initial velocity data  is  presented  as  eries 
of double reciprocal plots (according to  Equation 8 in  the  text).  The 
concentration of ATP  is  indicated in reciprocal form on the x axis, 
and  the corresponding concentration of Y-FSOsBzAdo is indicated  on 
the  graph. B, K,., values obtained  from  the  data  in A are  replotted 
as described by Segel  (35) to  determine K,. 
concentration of the analogue was constructed (Fig. 3 B ) .  
From  this  graph, K, = 0.0125  mM. They intercept of the  graph 
in Fig. 3B represents  the value of K,,, in the  absence of the 
inhibitor. This value (1.20 mM) agrees closely with the exper- 
imentally  determined value of K, (1.13 m ~ )  calculated  from 
a double reciprocal plot of data  obtained in the  absence of the 
inhibitor  (not  shown). 
Stoichiometry of Inactivation-The incorporation of 5‘- 
FS0,BzAdo was determined spectrophotometrically as de- 
scribed under  “Methods.”  The  data  presented in Fig. 4 dem- 
onstrates  that  there is a direct  correlation between the loss of 
enzymatic activity  and  the  incorporation f the analogue. The 
incorporation of radioactivity also correlated well with the 
inactivation.  Extrapolation of the  data (Fig. 4) indicates  that 
the  complete loss of enzymatic activity was concomitant with 
the  covalent  incorporation of approximately 1.09 mol of 5’- 
FS02BzAdo/mol of the  glutamine  synthetase  subunit. 
DISCUSSION AND CONCLUSION 
The inactivation of E.  coli glutamine synthetase by 5‘- 
FSOzBzAdo proceeds via the  formation of a  reversible, non- 
covalent Michaelis complex between the enzyme and the 
analogue prior to covalent binding. The formation of this 
complex is enhanced by L-glutamate. The effect of L-gluta- 
mate is significant because the binding of L-glutamate and 
ATP  has been  shown by others (11) to involve strong  syner- 
gism. Thus L-glutamate exerts  an effect on the binding of the 
nucleotide  analogue to  the enzyme that is similar to its effect 
on  the binding of the nucleotide substrate.  The inactivation 
of glutamine  synthetase by 5’-FS02BzAdo apparently  results 
from  the covalent attachment of the analogue to  an  amino 
acid residue at  or  near  the  ATP binding site of the active 
center,  as  demonstrated by the  protection  against  inactivation 
afforded by ATP  and  ADP. Given the  structure of  5’- 
FS02BzAdo, it seems likely that  the covalent bond formed 
during  the inactivation is  located  near  the  site of interaction 
of the  terminal  phosphate of ATP  with  the enzyme. The K,  
for  5”FSO*BzAdo (0.224 mM) compares favorably with the 
dissociation constant for ATP (-0.2 mM) as determined by 
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fluorescence (11) and sedimentation (34) studies. Thus, in the 
absence of added substrates, the enzyme has approximately 
the same binding affinity for the analogue as for the  substrate 
ATP. The value of Ki determined in the presence of substrate 
(0.0125 m, Fig. 3 B )  is considerably lower than the corre- 
sponding value obtained in the absence of substrate (0.224 
mM, Fig. 2 B ) .  Thus, although  our data indicate that reaction 
with 5”FS02BzAdo occurs at  the active center of glutamine 
synthetase, the possibility that covalent modification could 
occur at  some other site should not be overlooked. The 
resulting loss of activity could then arise from a conforma- 
tional change in the region of the active center. 
The inactivation of glutamine synthetase by  5’-FSOzBzAdo 
results from the incorporation of approximately 1 mol of the 
analogue/mol of subunit. The loss of catalytic activity paral- 
lels the incorporation of the analogue. These  results further 
indicate that  the reaction between glutamine synthetase and 
5’-FS02BzAdo occurs at  a single site on the enzyme, presum- 
ably the  ATP binding site. 
Based on the results of the present  study, 5”FSOzBzAdo 
can be used to probe further  the active center of glutamine 
synthetase and its interaction with nucleotide substrates. 
Studies are presently underway to identify the amino acid 
residue modified by 5”FSOzBzAdo and  to isolate and char- 
acterize a  tryptic peptide containing this modified residue. 
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